TGF-beta treatment modulates PD-L1 and CD40 expression in proximal renal tubular epithelial cells and enhances CD8+ cytotoxic T-cell responses

Nephron - Experimental Nephrology

Volumn 107, Issue 1, 2007, Pages

  Starke, Astrid ^a   Wüthrich, Rudolf P ^a,b   Waeckerle Men, Ying ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Cytotoxic T cells; Molecules, co stimulatory; Renal proximal tubular epithelial cells; Transforming growth factor

Indexed keywords

CD40 ANTIGEN; GAMMA INTERFERON; OVALBUMIN; PROGRAMMED DEATH LIGAND 1; PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; CD8+ T LYMPHOCYTE; CELL ACTIVITY; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DOWN REGULATION; EPITHELIUM CELL; FLOW CYTOMETRY; KIDNEY PROXIMAL TUBULE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANTIGENS, CD40; ANTIGENS, CD80; CELLS, CULTURED; DOWN-REGULATION; EPITHELIAL CELLS; EPITOPES; HISTOCOMPATIBILITY ANTIGENS CLASS I; INTERFERON TYPE II; KIDNEY TUBULES, PROXIMAL; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED STRAINS; OVALBUMIN; PEPTIDES; PHENOTYPE; T-LYMPHOCYTES, CYTOTOXIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 34548427279     PISSN: 16602129     EISSN: None     Source Type: Journal    
DOI: 10.1159/000106506     Document Type: Article

References (29)

1. Li MO, Wan YY, Sanjabi S, Robertson A-KL, Flavell RA: Transforming growth factor-β; Regulation of immune responses. Annu Rev Immunol 2006;24:99-146.
2. Rastaldi M, Tunesi S, Ferrario F, Indaco A, Zou H, Napodano P, D'Amico G: Transforming growth factor-β, endothelin-1, and c-fos expression in necrotizing/crescentic IgA glomerulonephritis. Nephrol Dial Transplant 1998;13:1668-1674.
3. Danilewicz M, Wagrowska-Danilewicz M: Correlative insights into the immunoexpression of transforming growth factor β-1 in acutely rejected renal allografts. Pathol Res Pract 2006;202:9-15.
4. Pribylova-Hribova P, Kotsch K, Lodererova A, Viklicky O, Vitko S, Volk HD, Lacha J: TGF-β1 mRNA upregulation influences chronic renal allograft dysfunction. Kidney Int 2006;69:1872-1879.
5. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Y, Pierschbacher MD, Ruoslahti E: Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature 1992;360:361-364.
6. Gagliardini E, Benigni A: Role of anti-TGF-β antibodies in the treatment of renal injury. Cytokine Growth Factor Rev 2006;17:89.
7. Becker GJ, Hewitson TD: The role of tubulointerstitial injury in chronic renal failure. Curr Opin Nephrol Hypertens 2000;9:133-138.
8. Fan J-M, Ng Y-Y, Hill PA, Nikolic-Paterson DJ, Mu W, Atkins RC, Lan HY: Transforming growth factor-β regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney Int 1999;56:1455-1467.
9. Rastaldi MP, Ferrario F, Giardino L, Dell'Antonio G, Grillo C, Grillo P, Strutz F, Muller GA, Colasanti G, D'Amico G: Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies. Kidney Int 2002;62:137-146.
10. Strutz F, Zeisberg M: Renal fibroblasts and myofibroblasts in chronic kidney disease. J Am Soc Nephrol 2006;17:2992-2998.
11. Yang J, Liu Y: Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol 2001;159:1465-1475.
12. + intraepithelial T cells. Transplantation 2003;75:505-514.
13. Wahl P, Schoop R, Bilic G, Neuweiler J, Le Hir M, Yoshinaga SK, Wuthrich RP: Renal tubular epithelial expression of the costimulatory molecule B7RP-1 (inducible costimulator ligand). J Am Soc Nephrol 2002;13:1517-1526.
14. Schoop R, Wahl P, Le Hir M, Heemann U, Wang M, Wuthrich RP: Suppressed T-cell activation by IFN-γ-induced expression of PD-L1 on renal tubular epithelial cells. Nephrol Dial Transplant 2004;19:2713-2720.
15. Waeckerle-Men Y, Starke A, Wuthrich RP: PD-L1 partially protects renal tubular epithelial cells from the attack of CD8+ cytotoxic T cells. Nephrol Dial Transplant 2007;22:1527-1536.
16. Yellin M, D'Agati V, Parkinson G, Han A, Szema A, Baum D, Estes D, Szabolcs M, Chess L: Immunohistologic analysis of renal CD40 and CD40L expression in lupus nephritis and other glomerulonephritides. Arthritis Rheum 1997;40:124-134.
17. Woltman AM, De Haij S, Boonstra JG, Gobin SJP, Daha MR, Kooten CV: Interleukin-17 and CD40-ligand synergistically enhance cytokine and chemokine production by renal epithelial cells. J Am Soc Nephrol 2000;11:2044-2055.
18. Kairaitis L, Wang Y, Zheng L, Tay Y-C, Wang Y, Harris DCH: Blockade of CD40-CD40 ligand protects against renal injury in chronic proteinuric renal disease. Kidney Int 2003;64:1265-1272.
19. Sime PJ, O'Reilly KMA: Fibrosis of the lung and other tissues: new concepts in pathogenesis and treatment. Clin Immunol 2001;99:308-319.
20. Pontrelli P, Ursi M, Ranieri E, Capobianco C, Schena FP, Gesualdo L, Grandaliano G: CD40L proinflammatory and profibrotic effects on proximal tubular epithelial cells: role of NF-κ B and Lyn. J Am Soc Nephrol 2006;17:627-636.
21. Giannopoulou M, Iszkula SC, Dai C, Tan X, Yang J, Michalopoulos GK, Liu Y: Distinctive role of Stat3 and Erk-1/2 activation in mediating interferon-γ inhibition of TGF-β1 action. Am J Physiol Renal Physiol 2006;290:F1234-F1240.
22. Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, Carbone FR: T cell receptor antagonist peptides induce positive selection. Cell 1994;76:17-27.
23. Wuthrich R, Glimcher L, Yui M, Jevnikar A, Dumas S, Kelley V: MHC class II, antigen presentation and tumor necrosis factor in renal tubular epithelial cells. Kidney Int 1990;37:783-792.
24. Meyers CM: New insights into the pathogenesis of interstitial nephritis. Curr Opin Nephrol Hypertens 1999;8:287-292.
25. Banu N, Meyers CM: TGF-β1 down-regulates induced expression of both class II MHC and B7-1 on primary murine renal tubular epithelial cells. Kidney Int 1999;56:985-994.
26. Peng X, Kasran A, Warmerdam P, de Boer M, Ceuppens J: Accessory signaling by CD40 for T cell activation: induction of Th1 and Th2 cytokines and synergy with interleukin-12 for interferon-gamma production. Eur J Immunol 1996;26:1621-1627.
27. van Kooten C, Gerritsma J, Paape M, van Es L, Banchereau J, Daha M: Possible role for CD40-CD40L in the regulation of interstitial infiltration in the kidney. Kidney Int 1997;51:711-721.
28. Rogers NJ, Jackson IM, Jordan WJ, Lombardi G, Delikouras A, Lechler RI: CD40 can costimulate human memory T cells and favors IL-10 secretion. Eur J Immunol 2003;33:1094-1104.
29. Jones ND, Van Maurik A, Hara M, Spriewald BM, Witzke O, Morris PJ, Wood KJ: CD40-CD40 ligand-independent activation of CD8+ T cells can trigger allograft rejection. J Immunol 2000;165:1111-1118.